Warnings
Mitsubishi Greint keine Substanz nachweisbar. Staðsetning: Vienna, Austurríki. Dagsetning: 2015-12-01. Uppruni: checkit.wien.
Mitsubishi-pilla — Vienna, Austurríki — 2015-12-01
Detected keine Substanz nachweisbar
Expected Unknown
Logo Mitsubishi
Color white
Location Vienna, Austria
Date 2015-12-01
Source checkit.wien
Media 2 images Appearance Logo: Mitsubishi Color: white Break line: 1 Media: 2 sample photos 3D model available in the interactive app Detected Substances keine Substanz nachweisbar Expected vs Detected No expected substance was recorded for this sample.
Detected result: keine Substanz nachweisbar
Sample Details Diameter: 8.08 mm Thickness: 3.67 mm Size: 8.08 Testing Context Location: Vienna, Austurríki Date tested: 2015-12-01 Source: checkit.wien Harm Reduction Similar-looking pills can contain different substances or strengths. Use drug checking services when available. Start low and avoid assuming a logo identifies the contents. SampleDNA Beta 53 tengdir viðvörunir · Leer meer over veelvoorkomende onzuiverheden.
keine Substanz nachweisbar Oppdaget Mostre și combinații asociate Keine Substanz nachweisbar 4 sýni · Núverandi niðurstaða
Gelijktijdig gedetecteerd in gerelateerde drug-checking-resultaten.
Mitsubishi logo 51 dæmi · Núverandi niðurstaða
Același logo apare în rezultatele corelate de verificare a drogurilor.
Wie Vorderseite logo 49 sýni
Același logo apare în rezultatele corelate de verificare a drogurilor.
MDMA Walter White, Wie Vorderseite · Vienna, Austurríki · 2016-12-01 MDMA Super Mario, Wie Vorderseite · Vienna, Austurríki · 2016-12-01 MDMA Flasche Spa, Wie Vorderseite · Vienna, Austurríki · 2016-11-01 MDMA Kurbis, Wie Vorderseite · Vienna, Austurríki · 2016-10-01 MDMA Tomorrowland, Wie Vorderseite · Vienna, Austurríki · 2016-09-01 MDMA Kleeblatt, Wie Vorderseite · Vienna, Austurríki · 2016-09-01 Geist logo 2 sýni
Același logo apare în rezultatele corelate de verificare a drogurilor.
SampleDNA skoðari
Links This static page is intended as the readable export baseline for crawler and low-capability delivery.